Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenues:
Total revenues	$ 66,263	$ 40,626
Expenses:
Cost of goods sold	3,819	5,530
Research and development	10,013	5,605
Selling	11,601	13,310
General and administrative	10,728	10,542
(Gain) loss on foreign currency transaction	(1,399)	954
Total expenses	49,541	46,624
Income (loss) from operations	16,722	(5,998)
Other income (expense):
Interest income, net	3,434	1,302
Interest expense on financing liability	(2,447)	(2,424)
Interest expense	(2,567)	(2,786)
Interest expense on liability for sale of future royalties	(4,248)
Other income		111
Total other expense	(5,828)	(3,797)
Income (loss) before income tax expense	10,894	(9,795)
Income tax expense	264
Net income (loss)	$ 10,630	$ (9,795)
Net income (loss) per share - basic	$ 0.04	$ (0.04)
Weighted average shares used to compute net income (loss) per share - basic	270,356	263,969
Net income (loss) per share - diluted	$ 0.04	$ (0.04)
Weighted average shares used to compute net income (loss) per share - diluted	324,733	263,969
Commercial product sales
Revenues:
Total revenues	$ 18,764	$ 17,562
Collaborations and services
Revenues:
Total revenues	24,848	11,386
Expenses:
Cost of revenue	14,779	10,683
Royalties
Revenues:
Total revenues	$ 22,651	$ 11,678